Global Biological Drugs Supply, Demand and Key Producers, 2023-2029

Description

The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.

This report studies the global Biological Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biological Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Drugs that contribute to its increasing demand across many markets.

The global Biological Drugs market size is expected to reach $ 495400 million by 2029, rising at a market growth of 7.8% CAGR during the forecast period (2023-2029).

The world biological drugs market is predicted to gain momentum with rising prevalence of chronic diseases such as cancer and diabetes across the globe. Demand for biological drugs could swell with the expansion of geriatric population at the global level. Currently growing inclination toward adoption of personalized medicines and strong research and development efforts taken to introduce new and powerful biological drugs are foretold to set the tone for a significant rise in demand.

Highlights and key features of the study
Global Biological Drugs total production and demand, 2018-2029, (Units)
Global Biological Drugs total production value, 2018-2029, (USD Million)
Global Biological Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Biological Drugs consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Biological Drugs domestic production, consumption, key domestic manufacturers and share
Global Biological Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Biological Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Biological Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units)
This reports profiles key players in the global Biological Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck and Abbott Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Biological Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Biological Drugs Market, Segmentation by Type
    Therapeutic Protein
    Monoclonal Antibody
    Vaccine
    Others

Global Biological Drugs Market, Segmentation by Application
    Hospitals
    Ambulatory Surgical Centers
    Others

Companies Profiled:
    Bristol-Myers Squibb
    Eli Lilly
    Takeda
    Pfizer
    Amgen
    F. Hoffmann-La Roche
    Johnson & Johnson
    Merck
    Abbott Laboratories
    Baxter
    Novartis
    Biogen
    GlaxoSmithKline

Key Questions Answered
1. How big is the global Biological Drugs market?
2. What is the demand of the global Biological Drugs market?
3. What is the year over year growth of the global Biological Drugs market?
4. What is the production and production value of the global Biological Drugs market?
5. Who are the key producers in the global Biological Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Biological Drugs Introduction
    1.2 World Biological Drugs Supply & Forecast
        1.2.1 World Biological Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Biological Drugs Production (2018-2029)
        1.2.3 World Biological Drugs Pricing Trends (2018-2029)
    1.3 World Biological Drugs Production by Region (Based on Production Site)
        1.3.1 World Biological Drugs Production Value by Region (2018-2029)
        1.3.2 World Biological Drugs Production by Region (2018-2029)
        1.3.3 World Biological Drugs Average Price by Region (2018-2029)
        1.3.4 North America Biological Drugs Production (2018-2029)
        1.3.5 Europe Biological Drugs Production (2018-2029)
        1.3.6 China Biological Drugs Production (2018-2029)
        1.3.7 Japan Biological Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Biological Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Biological Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Biological Drugs Demand (2018-2029)
    2.2 World Biological Drugs Consumption by Region
        2.2.1 World Biological Drugs Consumption by Region (2018-2023)
        2.2.2 World Biological Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Biological Drugs Consumption (2018-2029)
    2.4 China Biological Drugs Consumption (2018-2029)
    2.5 Europe Biological Drugs Consumption (2018-2029)
    2.6 Japan Biological Drugs Consumption (2018-2029)
    2.7 South Korea Biological Drugs Consumption (2018-2029)
    2.8 ASEAN Biological Drugs Consumption (2018-2029)
    2.9 India Biological Drugs Consumption (2018-2029)

3 World Biological Drugs Manufacturers Competitive Analysis
    3.1 World Biological Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Biological Drugs Production by Manufacturer (2018-2023)
    3.3 World Biological Drugs Average Price by Manufacturer (2018-2023)
    3.4 Biological Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Biological Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Biological Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Biological Drugs in 2022
    3.6 Biological Drugs Market: Overall Company Footprint Analysis
        3.6.1 Biological Drugs Market: Region Footprint
        3.6.2 Biological Drugs Market: Company Product Type Footprint
        3.6.3 Biological Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Biological Drugs Production Value Comparison
        4.1.1 United States VS China: Biological Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Biological Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Biological Drugs Production Comparison
        4.2.1 United States VS China: Biological Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Biological Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Biological Drugs Consumption Comparison
        4.3.1 United States VS China: Biological Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Biological Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Biological Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Biological Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Biological Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Biological Drugs Production (2018-2023)
    4.5 China Based Biological Drugs Manufacturers and Market Share
        4.5.1 China Based Biological Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Biological Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Biological Drugs Production (2018-2023)
    4.6 Rest of World Based Biological Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Biological Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Biological Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Biological Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Biological Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Therapeutic Protein
        5.2.2 Monoclonal Antibody
        5.2.3 Vaccine
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Biological Drugs Production by Type (2018-2029)
        5.3.2 World Biological Drugs Production Value by Type (2018-2029)
        5.3.3 World Biological Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Biological Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Ambulatory Surgical Centers
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Biological Drugs Production by Application (2018-2029)
        6.3.2 World Biological Drugs Production Value by Application (2018-2029)
        6.3.3 World Biological Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Bristol-Myers Squibb
        7.1.1 Bristol-Myers Squibb Details
        7.1.2 Bristol-Myers Squibb Major Business
        7.1.3 Bristol-Myers Squibb Biological Drugs Product and Services
        7.1.4 Bristol-Myers Squibb Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Bristol-Myers Squibb Recent Developments/Updates
        7.1.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.2 Eli Lilly
        7.2.1 Eli Lilly Details
        7.2.2 Eli Lilly Major Business
        7.2.3 Eli Lilly Biological Drugs Product and Services
        7.2.4 Eli Lilly Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Eli Lilly Recent Developments/Updates
        7.2.6 Eli Lilly Competitive Strengths & Weaknesses
    7.3 Takeda
        7.3.1 Takeda Details
        7.3.2 Takeda Major Business
        7.3.3 Takeda Biological Drugs Product and Services
        7.3.4 Takeda Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Takeda Recent Developments/Updates
        7.3.6 Takeda Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Biological Drugs Product and Services
        7.4.4 Pfizer Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 Amgen
        7.5.1 Amgen Details
        7.5.2 Amgen Major Business
        7.5.3 Amgen Biological Drugs Product and Services
        7.5.4 Amgen Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Amgen Recent Developments/Updates
        7.5.6 Amgen Competitive Strengths & Weaknesses
    7.6 F. Hoffmann-La Roche
        7.6.1 F. Hoffmann-La Roche Details
        7.6.2 F. Hoffmann-La Roche Major Business
        7.6.3 F. Hoffmann-La Roche Biological Drugs Product and Services
        7.6.4 F. Hoffmann-La Roche Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 F. Hoffmann-La Roche Recent Developments/Updates
        7.6.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    7.7 Johnson & Johnson
        7.7.1 Johnson & Johnson Details
        7.7.2 Johnson & Johnson Major Business
        7.7.3 Johnson & Johnson Biological Drugs Product and Services
        7.7.4 Johnson & Johnson Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Johnson & Johnson Recent Developments/Updates
        7.7.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.8 Merck
        7.8.1 Merck Details
        7.8.2 Merck Major Business
        7.8.3 Merck Biological Drugs Product and Services
        7.8.4 Merck Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Merck Recent Developments/Updates
        7.8.6 Merck Competitive Strengths & Weaknesses
    7.9 Abbott Laboratories
        7.9.1 Abbott Laboratories Details
        7.9.2 Abbott Laboratories Major Business
        7.9.3 Abbott Laboratories Biological Drugs Product and Services
        7.9.4 Abbott Laboratories Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Abbott Laboratories Recent Developments/Updates
        7.9.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.10 Baxter
        7.10.1 Baxter Details
        7.10.2 Baxter Major Business
        7.10.3 Baxter Biological Drugs Product and Services
        7.10.4 Baxter Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Baxter Recent Developments/Updates
        7.10.6 Baxter Competitive Strengths & Weaknesses
    7.11 Novartis
        7.11.1 Novartis Details
        7.11.2 Novartis Major Business
        7.11.3 Novartis Biological Drugs Product and Services
        7.11.4 Novartis Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Novartis Recent Developments/Updates
        7.11.6 Novartis Competitive Strengths & Weaknesses
    7.12 Biogen
        7.12.1 Biogen Details
        7.12.2 Biogen Major Business
        7.12.3 Biogen Biological Drugs Product and Services
        7.12.4 Biogen Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Biogen Recent Developments/Updates
        7.12.6 Biogen Competitive Strengths & Weaknesses
    7.13 GlaxoSmithKline
        7.13.1 GlaxoSmithKline Details
        7.13.2 GlaxoSmithKline Major Business
        7.13.3 GlaxoSmithKline Biological Drugs Product and Services
        7.13.4 GlaxoSmithKline Biological Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 GlaxoSmithKline Recent Developments/Updates
        7.13.6 GlaxoSmithKline Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Biological Drugs Industry Chain
    8.2 Biological Drugs Upstream Analysis
        8.2.1 Biological Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Biological Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Biological Drugs Production Mode
    8.6 Biological Drugs Procurement Model
    8.7 Biological Drugs Industry Sales Model and Sales Channels
        8.7.1 Biological Drugs Sales Model
        8.7.2 Biological Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Biological Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Biological Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Biological Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Biological Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Biological Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Biological Drugs Production by Region (2018-2023) & (Units)
    Table 7. World Biological Drugs Production by Region (2024-2029) & (Units)
    Table 8. World Biological Drugs Production Market Share by Region (2018-2023)
    Table 9. World Biological Drugs Production Market Share by Region (2024-2029)
    Table 10. World Biological Drugs Average Price by Region (2018-2023) & (USD/Unit)
    Table 11. World Biological Drugs Average Price by Region (2024-2029) & (USD/Unit)
    Table 12. Biological Drugs Major Market Trends
    Table 13. World Biological Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
    Table 14. World Biological Drugs Consumption by Region (2018-2023) & (Units)
    Table 15. World Biological Drugs Consumption Forecast by Region (2024-2029) & (Units)
    Table 16. World Biological Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Biological Drugs Producers in 2022
    Table 18. World Biological Drugs Production by Manufacturer (2018-2023) & (Units)
    Table 19. Production Market Share of Key Biological Drugs Producers in 2022
    Table 20. World Biological Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 21. Global Biological Drugs Company Evaluation Quadrant
    Table 22. World Biological Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Biological Drugs Production Site of Key Manufacturer
    Table 24. Biological Drugs Market: Company Product Type Footprint
    Table 25. Biological Drugs Market: Company Product Application Footprint
    Table 26. Biological Drugs Competitive Factors
    Table 27. Biological Drugs New Entrant and Capacity Expansion Plans
    Table 28. Biological Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Biological Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Biological Drugs Production Comparison, (2018 & 2022 & 2029) & (Units)
    Table 31. United States VS China Biological Drugs Consumption Comparison, (2018 & 2022 & 2029) & (Units)
    Table 32. United States Based Biological Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Biological Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Biological Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Biological Drugs Production (2018-2023) & (Units)
    Table 36. United States Based Manufacturers Biological Drugs Production Market Share (2018-2023)
    Table 37. China Based Biological Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Biological Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Biological Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Biological Drugs Production (2018-2023) & (Units)
    Table 41. China Based Manufacturers Biological Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Biological Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Biological Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Biological Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Biological Drugs Production (2018-2023) & (Units)
    Table 46. Rest of World Based Manufacturers Biological Drugs Production Market Share (2018-2023)
    Table 47. World Biological Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Biological Drugs Production by Type (2018-2023) & (Units)
    Table 49. World Biological Drugs Production by Type (2024-2029) & (Units)
    Table 50. World Biological Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Biological Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Biological Drugs Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. World Biological Drugs Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. World Biological Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Biological Drugs Production by Application (2018-2023) & (Units)
    Table 56. World Biological Drugs Production by Application (2024-2029) & (Units)
    Table 57. World Biological Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Biological Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Biological Drugs Average Price by Application (2018-2023) & (USD/Unit)
    Table 60. World Biological Drugs Average Price by Application (2024-2029) & (USD/Unit)
    Table 61. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 62. Bristol-Myers Squibb Major Business
    Table 63. Bristol-Myers Squibb Biological Drugs Product and Services
    Table 64. Bristol-Myers Squibb Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Bristol-Myers Squibb Recent Developments/Updates
    Table 66. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 67. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 68. Eli Lilly Major Business
    Table 69. Eli Lilly Biological Drugs Product and Services
    Table 70. Eli Lilly Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Eli Lilly Recent Developments/Updates
    Table 72. Eli Lilly Competitive Strengths & Weaknesses
    Table 73. Takeda Basic Information, Manufacturing Base and Competitors
    Table 74. Takeda Major Business
    Table 75. Takeda Biological Drugs Product and Services
    Table 76. Takeda Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Takeda Recent Developments/Updates
    Table 78. Takeda Competitive Strengths & Weaknesses
    Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 80. Pfizer Major Business
    Table 81. Pfizer Biological Drugs Product and Services
    Table 82. Pfizer Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Pfizer Recent Developments/Updates
    Table 84. Pfizer Competitive Strengths & Weaknesses
    Table 85. Amgen Basic Information, Manufacturing Base and Competitors
    Table 86. Amgen Major Business
    Table 87. Amgen Biological Drugs Product and Services
    Table 88. Amgen Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Amgen Recent Developments/Updates
    Table 90. Amgen Competitive Strengths & Weaknesses
    Table 91. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
    Table 92. F. Hoffmann-La Roche Major Business
    Table 93. F. Hoffmann-La Roche Biological Drugs Product and Services
    Table 94. F. Hoffmann-La Roche Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. F. Hoffmann-La Roche Recent Developments/Updates
    Table 96. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    Table 97. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 98. Johnson & Johnson Major Business
    Table 99. Johnson & Johnson Biological Drugs Product and Services
    Table 100. Johnson & Johnson Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Johnson & Johnson Recent Developments/Updates
    Table 102. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 103. Merck Basic Information, Manufacturing Base and Competitors
    Table 104. Merck Major Business
    Table 105. Merck Biological Drugs Product and Services
    Table 106. Merck Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Merck Recent Developments/Updates
    Table 108. Merck Competitive Strengths & Weaknesses
    Table 109. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
    Table 110. Abbott Laboratories Major Business
    Table 111. Abbott Laboratories Biological Drugs Product and Services
    Table 112. Abbott Laboratories Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Abbott Laboratories Recent Developments/Updates
    Table 114. Abbott Laboratories Competitive Strengths & Weaknesses
    Table 115. Baxter Basic Information, Manufacturing Base and Competitors
    Table 116. Baxter Major Business
    Table 117. Baxter Biological Drugs Product and Services
    Table 118. Baxter Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Baxter Recent Developments/Updates
    Table 120. Baxter Competitive Strengths & Weaknesses
    Table 121. Novartis Basic Information, Manufacturing Base and Competitors
    Table 122. Novartis Major Business
    Table 123. Novartis Biological Drugs Product and Services
    Table 124. Novartis Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Novartis Recent Developments/Updates
    Table 126. Novartis Competitive Strengths & Weaknesses
    Table 127. Biogen Basic Information, Manufacturing Base and Competitors
    Table 128. Biogen Major Business
    Table 129. Biogen Biological Drugs Product and Services
    Table 130. Biogen Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Biogen Recent Developments/Updates
    Table 132. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 133. GlaxoSmithKline Major Business
    Table 134. GlaxoSmithKline Biological Drugs Product and Services
    Table 135. GlaxoSmithKline Biological Drugs Production (Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 136. Global Key Players of Biological Drugs Upstream (Raw Materials)
    Table 137. Biological Drugs Typical Customers
    Table 138. Biological Drugs Typical Distributors
List of Figure
    Figure 1. Biological Drugs Picture
    Figure 2. World Biological Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Biological Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Biological Drugs Production (2018-2029) & (Units)
    Figure 5. World Biological Drugs Average Price (2018-2029) & (USD/Unit)
    Figure 6. World Biological Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Biological Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Biological Drugs Production (2018-2029) & (Units)
    Figure 9. Europe Biological Drugs Production (2018-2029) & (Units)
    Figure 10. China Biological Drugs Production (2018-2029) & (Units)
    Figure 11. Japan Biological Drugs Production (2018-2029) & (Units)
    Figure 12. Biological Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Biological Drugs Consumption (2018-2029) & (Units)
    Figure 15. World Biological Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Biological Drugs Consumption (2018-2029) & (Units)
    Figure 17. China Biological Drugs Consumption (2018-2029) & (Units)
    Figure 18. Europe Biological Drugs Consumption (2018-2029) & (Units)
    Figure 19. Japan Biological Drugs Consumption (2018-2029) & (Units)
    Figure 20. South Korea Biological Drugs Consumption (2018-2029) & (Units)
    Figure 21. ASEAN Biological Drugs Consumption (2018-2029) & (Units)
    Figure 22. India Biological Drugs Consumption (2018-2029) & (Units)
    Figure 23. Producer Shipments of Biological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological Drugs Markets in 2022
    Figure 26. United States VS China: Biological Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Biological Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Biological Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Biological Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Biological Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Biological Drugs Production Market Share 2022
    Figure 32. World Biological Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Biological Drugs Production Value Market Share by Type in 2022
    Figure 34. Therapeutic Protein
    Figure 35. Monoclonal Antibody
    Figure 36. Vaccine
    Figure 37. Others
    Figure 38. World Biological Drugs Production Market Share by Type (2018-2029)
    Figure 39. World Biological Drugs Production Value Market Share by Type (2018-2029)
    Figure 40. World Biological Drugs Average Price by Type (2018-2029) & (USD/Unit)
    Figure 41. World Biological Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Biological Drugs Production Value Market Share by Application in 2022
    Figure 43. Hospitals
    Figure 44. Ambulatory Surgical Centers
    Figure 45. Others
    Figure 46. World Biological Drugs Production Market Share by Application (2018-2029)
    Figure 47. World Biological Drugs Production Value Market Share by Application (2018-2029)
    Figure 48. World Biological Drugs Average Price by Application (2018-2029) & (USD/Unit)
    Figure 49. Biological Drugs Industry Chain
    Figure 50. Biological Drugs Procurement Model
    Figure 51. Biological Drugs Sales Model
    Figure 52. Biological Drugs Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source